Is There a change of corneal thickness in uveitis with behçet disease?

Cornea

Volumn 29, Issue 11, 2010, Pages 1265-1267

  Ozdamar, Yasemin ^a   Berker, Nilufer ^a   Ertugrul, Gokhan ^a   Gurlevik, Ugur ^a   Karakaya, Jale ^b   Ozkan, Seyhan S ^a  

^a Ankara Ulucanlar Eye Research Hospital   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Beh et disease; central corneal thickness; uveitis

Indexed keywords

ADULT; ARTICLE; BEHCET DISEASE; CONTROLLED STUDY; CORNEA THICKNESS; DISEASE DURATION; EYE INFLAMMATION; HUMAN; IRIDOCYCLITIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; ULTRASOUND; UVEITIS;

ADULT; ANTERIOR CHAMBER; BEHCET SYNDROME; CORNEA; FEMALE; HUMANS; INFLAMMATION; MALE; UVEITIS;

EID: 78149279663     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181d142b3     Document Type: Article

References (20)

1. Deuter CM, Kötter I, Wallace GR, et al. Behxcet's disease: ocular effects and treatment. Prog Retin Eye Res. 2008;27:111-136.
2. Bonfioli AA, Orefice F. Behxcet's disease. Semin Ophthalmol. 2005;20: 199-206.
3. Macdonald JM, Geroski DH, Edelhauser HF. Effect of inflammation on the corneal endothelial pump and barrier. Curr Eye Res. 1987;6: 1125-1132.
4. Olsen T. Changes in the corneal endothelium after acute anterior uveitis as seen with the specular microscope. Acta Ophthalmol. 1980;58:250-256.
5. Olsen T. Transient changes in specular appearance of the corneal endothelium and in corneal thickness during anterior uveitis. Acta Ophthalmol. 1981;59:100-109.
6. Brooks AMV, Grant G, Gillies WE. The use of specular microscopy to investigate unusual findings in the corneal endothelium and its adjacent structures. Aust N Z J Ophthalmol. 1988;16:235-243.
7. Brooks AMV, Grant G, Gillies WE. Differentiation and assessment of corneal endothelial changes associated with diseases of the anterior segment of the eye. Aust N Z J Ophthalmol. 1987;15:65-70.
8. Pillai CT, Dua HS, Azuara-Blanco A, et al. Evaluation of corneal endothelium and keratic precipitates by specular microscopy in anterior uveitis. Br J Ophthalmol. 2000;84:1367-1371.
9. Evereklioglu C, Er H. Increased corneal thickness in active Behxcet's disease. Eur J Ophthalmol. 2002;12:24-29.
10. Behar-Cohen FF, Savoldelli M, Parel JM, et al. Reduction of corneal edema in endotoxin-induced uveitis after application of L-NAME as nitric oxide synthase inhibitor in rats by iontophoresis. Invest Ophthalmol Vis Sci. 1998;39:897-904.
11. Ehlers N, Hjortdal J. Corneal thickness: measurement and implications. Exp Eye Res. 2004;78:543-548.
12. Bourne WM, McLaren JW. Clinical responses of the corneal endothelium. Exp Eye Res. 2004;78:561-572
13. The International Study Group for Behcet's disease. Evaluation of diagnostic (classification) criteria in Behcet's disease\towards internationally agreed criteria. Br J Rheumatol. 1992;31:299-308.
14. Jorizzo JL, Hudson RD, Schmalstieg FC, et al. Behxcet's syndrome: immune regulation, circulating immune complexes, neutrophil migration, and colchicine therapy. J Am Acad Dermatol. 1984;10:205-214.
15. Evereklioglu C, Er H, Türköz Y, et al. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behxcet's disease. Mediators Inflamm. 2002;11:87-93.
16. Sahin S, Akoglu T, Direskeneli H, et al. Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behxcet's disease. Ann Rheum Dis. 1996;55:128-133.
17. De Vos AF, Hoekzema R, Kijlstra A. Cytokines and uveitis, a review. Curr Eye Res. 1992;11:581-597.
18. Gül A. Behxcet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy. 2005;4:81-83.
19. Ahn JK, Yu HG, Chung H, et al. Intraocular cytokine environment in active Behxcet uveitis. Am J Ophthalmol. 2006;142:429-434.
20. Tugal-Tutkun I, Cingü K, Kir N, et al. Use of laser flare-cell photometry to quantify intraocular inflammation in patients with Behxcet uveitis. Graefes Arch Clin Exp Ophthalmol. 2008;246:1169-1177.